1-7 of 7
Douglas K. Price
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Antitumor Activity of NLG207 (Formerly CRLX101) in Combination with Enzalutamide in Preclinical Prostate Cancer Models

Available to Purchase
Keith T. Schmidt, Cindy H. Chau, Jonathan D. Strope, Alwin D.R. Huitema, Tristan M. Sissung, Douglas K. Price, William D. Figg
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (5): 915–924.
https://doi.org/10.1158/1535-7163.MCT-20-0228
Published: 01 May 2021
View articletitled, Antitumor Activity of NLG207 (Formerly CRLX101) in Combination with Enzalutamide in Preclinical Prostate Cancer Models
Open the PDF for Antitumor Activity of NLG207 (Formerly CRLX101) in Combination with Enzalutamide in Preclinical Prostate Cancer Models in another window
Includes: Supplementary data
Journal Articles

Abstract A069: Mechanisms governing the transcriptional regulation of the liver-specific transporter OATP1B3 in prostate cancer

Free
Roberto H Barbier, Edel M McCrea, Jonathan D Strope, Phoebe A Huang, Tristan M Sissung, Douglas K Price, Cindy H Chau, William D Figg
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2019) 18 (12_Supplement): A069.
https://doi.org/10.1158/1535-7163.TARG-19-A069
Published: 01 December 2019
View articletitled, Abstract A069: Mechanisms governing the transcriptional regulation of the liver-specific transporter OATP1B3 in prostate cancer
Journal Articles

Abstract B28: Organic anion transporting polypeptide 1B3 as a novel biomarker for hypoxia in prostate cancer.

Free
Heather M. Pressler, Stephen Pisle, Tristan M. Sissung, Cheryl D. Cropp, Douglas K. Price, William D. Figg
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): B28.
https://doi.org/10.1158/1535-7163.TARG-11-B28
Published: 12 November 2011
View articletitled, Abstract B28: Organic anion transporting polypeptide 1B3 as a novel biomarker for hypoxia in prostate cancer.
Journal Articles

The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors

Free
Lokesh Jain, Craig A. Vargo, Romano Danesi, Tristan M. Sissung, Douglas K. Price, David Venzon, Jürgen Venitz, William D. Figg
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (9): 2496–2508.
https://doi.org/10.1158/1535-7163.MCT-09-0302
Published: 17 September 2009
View articletitled, The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors
Open the PDF for The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors in another window
Includes: Supplementary data
Journal Articles

Ethnic disparities in Americans of European descent versus Americans of African descent related to polymorphic ERCC1, ERCC2, XRCC1, and PARP1

Free
Rui Gao, Douglas K. Price, Tristan Sissung, Eddie Reed, William D. Figg
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (5): 1246–1250.
https://doi.org/10.1158/1535-7163.MCT-07-2206
Published: 15 May 2008
View articletitled, Ethnic disparities in Americans of European descent versus Americans of African descent related to polymorphic ERCC1, ERCC2, XRCC1, and PARP1
Open the PDF for Ethnic disparities in Americans of European descent versus Americans of African descent related to polymorphic ERCC1, ERCC2, XRCC1, and PARP1 in another window
Journal Articles

Association of the CYP1B1*3 allele with survival in patients with prostate cancer receiving docetaxel

Free
Tristan M. Sissung, Romano Danesi, Douglas K. Price, Seth M. Steinberg, Ronald de Wit, Muhammad Zahid, Nilesh Gaikwad, Ercole Cavalieri, William L. Dahut, Dan L. Sackett, William D. Figg, Alex Sparreboom
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (1): 19–26.
https://doi.org/10.1158/1535-7163.MCT-07-0557
Published: 17 January 2008
View articletitled, Association of the CYP1B1*3 allele with survival in patients with prostate cancer receiving docetaxel
Open the PDF for Association of the CYP1B1*3 allele with survival in patients with prostate cancer receiving docetaxel in another window
Journal Articles

Anti-angiogenic activity of human endostatin is HIF-1-independent in vitro and sensitive to timing of treatment in a human saphenous vein assay

Free
Gordon R. Macpherson, Sylvia S.W. Ng, Siiri L. Forbes, Giovanni Melillo, Tatiana Karpova, James McNally, Thomas P. Conrads, Timothy D. Veenstra, Alfredo Martinez, Frank Cuttitta, Douglas K. Price, William D. Figg
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2003) 2 (9): 845–854.
Published: 10 October 2003
View articletitled, Anti-angiogenic activity of human endostatin is HIF-1-independent in vitro and sensitive to timing of treatment in a human saphenous vein assay
Open the PDF for Anti-angiogenic activity of human endostatin is HIF-1-independent in vitro and sensitive to timing of treatment in a human saphenous vein assay in another window